Kappa Opioid Receptor Mediated Differential Regulation of Serotonin and Dopamine Transporters in Mood and Substance Use Disorder
- PMID: 34136961
- DOI: 10.1007/164_2021_499
Kappa Opioid Receptor Mediated Differential Regulation of Serotonin and Dopamine Transporters in Mood and Substance Use Disorder
Abstract
Dynorphin (DYN) is an endogenous neurosecretory peptide which exerts its activity by binding to the family of G protein-coupled receptors, namely the kappa opioid receptor (KOR). Opioids are associated with pain, analgesia, and drug abuse, which play a central role in mood disorders with monoamine neurotransmitter interactions. Growing evidence demonstrates the cellular signaling cascades linked to KOR-mediated monoamine transporters regulation in cell models and native brain tissues. This chapter will review DYN/KOR role in mood and addiction in relevance to dopaminergic and serotonergic neurotransmissions. Also, we discuss the recent findings on KOR-mediated differential regulation of serotonin and dopamine transporters (SERT and DAT). These findings led to a better understanding of the role of DYN/KOR system in aminergic neurotransmission via its modulatory effect on both amine release and clearance. Detailed knowledge of these processes at the molecular level enables designing novel pharmacological reagents to target transporter motifs to treat mood and addiction and reduce unwanted side effects such as aversion, dysphoria, sedation, and psychomimesis.
Keywords: Addiction; Dopamine transporter; Dynorphin; Kappa opioid receptor; Mood; Serotonin transporter; Signaling.
© 2021. The Author(s), under exclusive license to Springer Nature Switzerland AG.
Similar articles
-
Salvinorin A regulates dopamine transporter function via a kappa opioid receptor and ERK1/2-dependent mechanism.Neuropharmacology. 2014 Nov;86:228-40. doi: 10.1016/j.neuropharm.2014.07.016. Epub 2014 Aug 10. Neuropharmacology. 2014. PMID: 25107591 Free PMC article.
-
Threonine-53 Phosphorylation of Dopamine Transporter Dictates κ-Opioid Receptor-Mediated Locomotor Suppression, Aversion, and Cocaine Reward.J Neurosci. 2025 Jun 18;45(25):e0171252025. doi: 10.1523/JNEUROSCI.0171-25.2025. J Neurosci. 2025. PMID: 40393807
-
Stress produces aversion and potentiates cocaine reward by releasing endogenous dynorphins in the ventral striatum to locally stimulate serotonin reuptake.J Neurosci. 2012 Dec 5;32(49):17582-96. doi: 10.1523/JNEUROSCI.3220-12.2012. J Neurosci. 2012. PMID: 23223282 Free PMC article.
-
Dynorphin/Kappa Opioid Receptor Signaling in Preclinical Models of Alcohol, Drug, and Food Addiction.Int Rev Neurobiol. 2017;136:53-88. doi: 10.1016/bs.irn.2017.08.001. Epub 2017 Sep 12. Int Rev Neurobiol. 2017. PMID: 29056156 Review.
-
Dynorphin/Kappa-Opioid Receptor System Modulation of Cortical Circuitry.Handb Exp Pharmacol. 2022;271:223-253. doi: 10.1007/164_2021_440. Handb Exp Pharmacol. 2022. PMID: 33580392 Review.
Cited by
-
Resolution of tonic concentrations of highly similar neurotransmitters using voltammetry and deep learning.Mol Psychiatry. 2024 Oct;29(10):3076-3085. doi: 10.1038/s41380-024-02537-1. Epub 2024 Apr 25. Mol Psychiatry. 2024. PMID: 38664492 Free PMC article.
-
Role of Phosphorylation of Serotonin and Norepinephrine Transporters in Animal Behavior: Relevance to Neuropsychiatric Disorders.Int J Mol Sci. 2025 Aug 9;26(16):7713. doi: 10.3390/ijms26167713. Int J Mol Sci. 2025. PMID: 40869034 Free PMC article. Review.
-
Kappa Opioid Receptors Reduce Serotonin Uptake and Escitalopram Efficacy in the Mouse Substantia Nigra Pars Reticulata.Int J Mol Sci. 2023 Jan 20;24(3):2080. doi: 10.3390/ijms24032080. Int J Mol Sci. 2023. PMID: 36768403 Free PMC article.
-
The role of enkephalinergic systems in substance use disorders.Front Syst Neurosci. 2022 Aug 5;16:932546. doi: 10.3389/fnsys.2022.932546. eCollection 2022. Front Syst Neurosci. 2022. PMID: 35993087 Free PMC article. Review.
References
-
- Arvidsson U, Riedl M, Chakrabarti S, Vulchanova L, Lee JH, Nakano AH, Lin X, Loh HH, Law PY, Wessendorf MW et al (1995) The kappa-opioid receptor is primarily postsynaptic: combined immunohistochemical localization of the receptor and endogenous opioids. Proc Natl Acad Sci U S A 92:5062–5066 - PubMed - PMC
-
- Ballenger JC (1999) Current treatments of the anxiety disorders in adults. Biol Psychiatry 46:1579–1594 - PubMed
-
- Beardsley PM, Howard JL, Shelton KL, Carroll FI (2005) Differential effects of the novel kappa opioid receptor antagonist, JDTic, on reinstatement of cocaine-seeking induced by footshock stressors vs cocaine primes and its antidepressant-like effects in rats. Psychopharmacology (Berl) 183:118–126
-
- Bengel D, Murphy DL, Andrews AM, Wichems CH, Feltner D, Heils A, Mossner R, Westphal H, Lesch KP (1998) Altered brain serotonin homeostasis and locomotor insensitivity to 3,4-methylenedioxymetamphetamine (“ecstasy”) in serotonin transporter-deficient mice. Mol Pharmacol 53:649–655 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical